The COVID pandemic set in motion trends with alcohol use that have persisted. Disruptions in work, school and lifestyle have ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...

And actually, as the GLP-1s have actually continued to expand throughout the community, that’s where many of the initial ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

A study found that GLP-1 RA use is linked to risks for retained gastric contents during single endoscopic procedures but not ...

With only one approved drug on the market, companies like Inventiva Pharma are advancing MASH drugs and seeking a competitive ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Study estimates 136.8 million U.S. adults are eligible for semaglutide, a popular therapy for diabetes, weight loss, and cardiovascular disease.

The efficacy of GLP-1s has made them a breakthrough not only in managing obesity and diabetes, but also in their potential to ...

Wondr Plus delivers improved metabolic health outcomes and meaningful ROI for employers ready to tackle workforce obesity ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...